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 In orthotopic liver transplantation from Lewis (LEW) 
into Wistar Furth (WF) rats, a transient acute rejection re-
sponse is usually followed by spontaneous tolerance of the 
graft. In this study, we investigated the alloimmunostimulatory 
ability of the graft and recipient spleen after liver trans-
plantation, and studied the kinetic response of the recipient 
to the donor antigen. Alloimmunogenicity of the liver graft 
and recipient spleen, and kinetic response of the recipient 
were investigated in in vivo system. Alloimmunostimulatory 
ability of the liver graft disappeared by day 3 after trans-
plantation. Alloimmunostimulatory capacity of recipient 
spleen was maximum 12 hours after grafting and rapidly 
disappeared thereafter. Challenge with normal LEW lym-
phocytes into recipient WF rats at 14, 28, 56 days after 
liver transplantation induced a progressive increase in re-
jection response. Our results suggest that rapid loss of 
graft immunogenicity and transient hyporesponsiveness to 
the donor antigen occur after grafting in our model.
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Introduction
 In alloantigen recognition, recipient T cells directly 
respond to major histocompatibility complex (MHC) 
class I and II molecules on donor antigen presenting 
cells (APCs).1-3' This direct recognition is responsible 
for the in vitro response to alloantigens, and likely re 
lates to the acute rejection response in transplantation."
Dendritic cells are the most effective APCs" and are 
known to overexpress MHC class I and II antigens, ad-
hesion and costimulatory molecules.'-") Furthermore, 
cells obtained from solid organs show potent allo-
immunostimulatory activity in vitro.","' On the other 
hand, donor passenger leukocytes disappear from the 
kidney,',"' heart") and skin") grafts, an event consid 
ered to be an essential mechanism for graft tolerance.",") 
However, only a few studies have examined the kinet-
ics of graft alloimmunogenicity. 
 Transplantation tolerance can be induced by various 
immunosuppressive modalities, although liver grafts 
are often spontaneously accepted in some strain com-
binations of laboratory animals."-'O) The underlying 
mechanisms involved in the spontaneous tolerance of 
the transplanted liver have been proposed."-") Studies 
from our laboratories have previously demonstrated 
that primed cytotoxic T lymphocyte precursors (CTLp) 
were eliminated or inactivated in long-term surviving 
recipient WF rats, while non-primed CTLp, which me-
diated the rejection response to the grafted liver, were 
present but graft immunogenicity disappeared in toler-
ant rats.") We have suggested that these findings were 
responsible for the development and maintenance of 
tolerance. 
 In the present study, we examined kinetics of the 
immunostimulatory ability of the transplanted liver 
and immune response of the recipient to the donor an 
tigen. Our results showed that the graft immunogenicity 
disappeared rapidly after liver transplantation. There 
was also a transient hyporesponsiveness of the recipi-
ent to the donor antigen during early phase of the 
transplantation.
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Materials and Methods
Animals 
 Male Lewis (LEW, RT-1 A' B' D') rats weighing 230-
280g were purchased from Shizuoka Laboratory Animal 
Center (Shizuoka, Japan). Male Wistar Furth (WF, RT-
1 A° B" D°) rats weighing 250-320g were obtained from 
a colony maintained in the Laboratory Animal Center 
for Biomedical Research, Nagasaki University School 
of Medicine. The experimental protocol was approved 
by the Ethics Review Committees for Animal Experi-
mentation of the participating institutions.
Measurement of serum transaminase and total bilirubin 
 Blood samples were obtained from the tail vein of re-
cipient WF rats at specific time intervals. Serum glut-
amic pyruvic transaminase (SGPT) and total bilirubin 
(TB) were measured using an autoanalyzer (UVIDEC-
77, Japan Spectroscopic Co., Tokyo, Japan). Normal val-
ues for SGPT and TB are below 351U/L and 0.4mg/dl, 
respectively.
for 30 min at 4°C. After duplicate washing with RPMI 
1640, cells were suspended in 0.5mM EDTA-PBS 
(Nacalai Tesque Inc., Kyoto, Japan) with 5 % FCS and 
placed in dishes (2 x 107/dish) followed by incubation 
for 120min at room temperature. Nonadherent cells (2-
4 x 107) in the dishes were cultured with LEW anti-
WF antiserum and panned again. Nonadherent cells in 
the dishes were then gently harvested for flow cyto-
metric analysis.
Flow cytometric analysis 
 Cells were incubated with WF anti-LEW antiserum, 
diluted (1:100) with Eagle's MEM for 30 min at VC. 
After washing twice with PBS, cells were incubated 
with FITC-labeled goat anti-rat IgG (Fc) (Chemicon 
International Inc., Temecula, CA), diluted 1:100) for 30 
min at 4°C. After washing twice with PBS, cells were 
suspended in PBS and examined in a FACScan (Becton 
Dickinson, Mountain View, CA). Cells (1 x 10') were 
sorted and single histograms were obtained after set-
gating on small lymphcyte popuration to concentrate 
the analysis.
Preparation of alloantibody 
 Female LEW and WF rats (5-8 weeks old) were in 
oculated intraperitoneally with WF or LEW spleen cells 
(1-2 x 108) once a week, respectively. Ten days after 
the 5th such inoculation, sera obtained from live rats 
were used as an antibody against MHC alloantigens.
Preparation of nylon-wool adherent and nonadherent cells 
 Spleen cells (2 x 108) from LEW liver-transplanted 
WF rats were incubated in a nylon-wool column for 
30min at 37°C under 5% CO2 in air. After addition of 
50m1 RPMI 1640 to the nylon-wool column, the cells 
obtained by crumpling the nylon-wool were used as the 
adherent cells and passed through the column were 
used as the nonadherent cells.
Cell panning 
 Petri dishes (60mm, Falcon 1016, Becton Dickinson, 
Meylanm Cedax, France) were coated with 20,u g/ml 
of rabbit anti-rat IgG (Fc) (Bethyl Laboratories Inc., 
Montgomery, AL) in 50mM Tris-HC1 buffer (pH 9.5) 
for 120 min at room temperature. After washing twice 
with 0.15 M NaCI, the dishes were incubated overnight 
with 3m1 BSA (1 mg/ml) in PBS at room temperature. 
Spleen cells (3 x 108) suspended in RPMI 1640 were 
cultured with LEW anti-WF antiserum (diluted 1:20)
Surgical preparation 
 Orthotopic liver transplantation was performed ac-
cording to the cuff and nonarterialized method with-
out immunosuppression.31> Bile duct anastomosis was 
performed using a silastic stent tube (0.6mm OD). In 
the donor operation, after systemic administration of 
100 units of heparin, the liver was first perfused 
through the portal vein with 10ml of ice-cold lactated 
Ringer's solution containing 10units / ml of heparin, 
then removed and placed in 4C lactated Ringer's solu-
tion. Donor operation lasted approximately 30 min. 
Following removal of the recipient liver, the donor 
liver was orthotopically placed in the recipient and the 
suprahepatic inferior vena cava was anastomosed with 
7-0 nylon, using a continuous suture technique. The 
unhepatic period was < 16 min and the recipient op-
eration lasted approximately 60 min. All procedures 
were performed by the same surgeon (WG). 
 Skin transplantation was performed using fullthickness 
grafts, 1.5 x 1.5cm in size. Rejection of skin grafts was 
determined when 90% of the graft became necrotic.
Intraperitoneal challenge with homogenized liver or spleen 
cells into long-term surviving recipient WF rats with a 
LEW liver transplant 
 The liver was perfused through the portal vein with 
20ml of ice-cold lactated Ringer's solution containing
10units/ml of heparin, Then it was removed and ho-
mogenized in a manual homogenizer. The homogenate 
pelleted by centrifugation for 5 min at 1,000 rpm was 
then injected intraperitoneally into recipient WF rats 
that survived for > 100 days after transplantation and 
showed no serological evidence of liver dysfunction. 
Liver homogenates consisted microscopically of paren-
chymal and nonparenchymal cells. After intraperitoneal 
injection of liver homogenates, blood samples were ob-
tained on days 0, 5, 6 and 14. Spleen cells from recipi-
ent WF rats were also prepared and intraperitoneally 
injected into another recipient WF rats with LEW 
liver transplants.
In vivo administration of CsA 
 In some experiment, CsA (3mg/kg/day) was admin-
istered intramuscularly into naive WF rats on days 2, 
1 and 0 before liver transplantation.
Statistical analysis 
 All data were expressed as mean ± standard devia-
tion (SD). Differences between groups were examined 
for statistical significance using the Student's t-test. A 
P value less than 0.05 denoted the presence of a sta-
tistically significant difference.
Results
Fig. 1. (A) Serum levels of glutamic pyruvic transamimase 
and (B) total bilirubin after liver transplantation. For A and 
B, LEW livers were orthotopically transplanted into WF (S) 
and LEW (0) rats. Each group consisted of 6-8 rats.
Transient rejection response in recipient WF rats after 
orthotopic transplantation of LEW liver 
 Orthotopically transplanted LEW liver was accepted 
in WF rats without immunosuppressive therapy, and 
recipient rats survived for > 200 days except for tech-
nical failure. We first carried on the day course study 
of liver damage to examine the peak of serological re-
jection responses after transplantation. As shown in 
Fig. 1. SGPT and TB levels increased and reached 
peak values on day 4, but returned to normal levels 
within 14 and 28 days, respectively. When the LEW 
liver was transplanted into LEW rats, SGPT but not 
TB level slightly increased on one day but rapidly de-
creased thereafter. Histologically, cellular infiltrates 
around the portal tract and in sinusoids were observed 
in the grafted LEW liver in recipient WF, but not LEW 
rats 4 days post-transplantation (Fig. 2A, B). Cellular 
infiltration was most evident 2-3 weeks after grafting 
(Fig. 2C), but was markedly decreased in the grafted 
LEW liver obtained from long-term surviving recipient 
WF rats (Fig. 2D).
Table 1. SGPT in the long-term surviving recipient WF rats 
after an intraperitoneal challenge with liver homogenates
                             SGPT (IU/L)" 
Inoculated tissues 
                            0 5 6 14(days)' 
Normal PVG liver homogenates 30±4 35±4 31±6 25±3 
Normal LEW liver homogenates 
  50%` 24±4 235±57 242±43 19±2 
  10% 30±4 244±52 202±68 28±4 
  5% 23±5 97±39 199±23 27±7 
Grafted LEW liver homogenates from WF rat 
  
1 day' 27±6 127±19 121±13 31±4 
  2 day 24±3 40±11 83±19 26±5 
  3 day 29±7 30±6 28±5 27±4 
  7 say 30±5 27±4 31±2 29±3 
  14 day 25±2 27±2 22±3 28±3 
Grafted LEW liver homogenates from LEW rat 
  3 days 22±4 223±51 219±37 24±7 
  14 day 24±5 182±57 215±48 24±4 
Grafted LEW liver homogenates from WF rat 
  plus normal LEW liver homogenates 29±5 215±59 179±46 32±4
Values represent mean ± SD; n=3. 
'Days after intraperitoneal challenge . 
`% homogenates of the total liver volume from a normal LEW rat . 
°Time when grafted LEW liver homogenates were obtained after grafting .
Loss of alloimmunostimulatory ability of LEW liver grafts 
in recipient WF rats 
 In the next step, we investigated kinetics of the 
alloimmunostimulatory ability of the graft following 
LEW liver transplantation. As shown in Table 1. intra-
peritoneal challenge using 50% homogenates of the 
total liver volume from third-party PVG (RT-1 AcB° D` ) 
rats into long-term surviving recipient WF rats did 
not induce a rise in SGPT levels althouth it efficiently
sensitized WF animals for PVG skin grafts (data not 
shown). Challenge with normal LEW liver homogen-
ates (> 5% volume) induced a transient rise in SGPT 
levels, which reached a peak level on days 5-6. In the 
following experiments, we used > 50% homogenates of 
the total liver volume for intraperitoneal challenge. 
 Challenge with grafted LEW liver homogenates ob-
tained from recipient WF rats on days 1 and 2, but 
not on days 3, 7 or 14 post-transplantation, induced a 
transient rise in SGPT levels. Grafted LEW liver ho-
mogenates obtained from syngeneic recipient LEW 
rats on days 3 and 14 after transplantation induced a 
transient elevation of SGPT levels. Challenge with 
grafted LEW liver homogenates from recipient WF rats 
obtained on day 3 together with the normal LEW liver
homogenate (volume ratio, 3 : 1) led to a transient ele-
vation of SGPT levels. These results suggested absence 
of suppressive factors in the grafted LEW liver. Admin-
istration of normal LEW liver homogenates into naive 
WF and LEW rats did not increase SGPT levels (data 
not shown). Histological changes in the grafted LEW 
liver in long-term surviving recipient WF rats 7 days 
after intraperitoneal administration of normal LEW 
liver homogenates included cellular infiltration around 
the portal tract, focal liver necrosis and regeneration 
of hepatocytes (Fig. 2E). These changes were not ob-
served in rats injected with grafted LEW liver ho-
mogenates obtained from recipient WF rats on day 3 
post-transplantation (Fig. 2F).
Fig. 2. Histological appearance (hematoxylin and eosin staining) of grafted LEW liver. Grafted LEW livers from recipient LEW 
(A) and WF (B) rats were obtained on day 4 after transplantation. In C, grafted LEW livers from recipient WF rats were 
Obtained on day 14 after transplantation. In LEW to WF rat combination, grafted LEW livers were obtained from long-term 
surviving recipient WF rats before (D) and 7 days after (E) intraperitoneal administration of normal LEW liver homogenates. 
The same animals were used for this kinetic study (D and E). For F, grafted LEW livers were obtained from long-term surviv-
ing recipient WF rats on 7 days after intraperitoneal administrattion of grafted LEW livers, which were gained from recipient 
WF rats on day 3 after transplantation. (Magnification, A, B, C, D, E, F, x100,).
Alloimmunostimulatory ability of recipient WF splenocytes 
after LEW liver grafting 
 We examined alloimmunostimulatory ability of re-
cipient WF spleen cells (Table 2). No elevation of 
SGPT levels was observed following intraperitoneal ad-
ministration of spleen cells (6 x 108) from naive WF 
rat into long-term surviving recipient WF rats. Intra-
peritoneal challenge with spleen cells (2 x 10') from 
naive LEW rat induced a transient elevation of SGPT 
levels. In the following experiments, we used spleens 
from two WF recipient rats.
Table 2. SGPT in the long-term surviving recipient WF rats 
after an intraperitoneal challenge with spleen cells
                             SGPT (IU/L)" 
Inoculated tissues 
0 5 6 14(days)b 
Normal WF spleen cells 27±5 29±4 21±4 25±3 
Normal LEW spleen cells 24±6 250±69 296±42 26±7 
Recipient WF spleen cells after LEW liver grafting 
  3 hours` 24±3 29±4 36±3 33±3 
  12 hours 24±9 128±21 96±27 24±6 
  12 hours (nylon-wool abherent cells) 29±3 106±23 132±29 23±7 
  12 hours (nylon-wool nonadherent cells) 26±3 31±5 28±4 27±4 
  24 hours 27±8 43±25 60±17 25±3 
  2 day 22±4 27±3 30±5 26±6 
  2 day (CsA-treated) 27±5 65±5 73±21 30±5 
  3 day 24±5 22±2 30±5 29±4
Values represent mean ± SD; n=3. 
'Days after intraperitoneal challenge . 
`Time when recipient WF spleen cells were obtained after grafting .
 In long-term surviving recipient WF rats, intra-
peritoneal challenge with spleen cells from different re-
cipient WF rats obtained 3 hours after LEW liver trans-
plantation did not induce a transient elevation of SGPT 
level. However, spleen cells obtained 12 and 24 hours 
after grafting induced a transient elevation of SGPT 
level. Challenge with spleen cells obtained 12 hours 
after grafting was associated with the highest SGPT 
levels. Intraperitoneal challenge using spleen cells ob-
tained at 2-3 days after LEW liver grafting did not in-
duce a rise in SGPT level. We also investigated the 
immunostimulatory ability of spleen cells that had 
been passed through a nylon-wool column. Nylon-wool 
adherent but not nonadherent recipient WF spleen 
cells obtained 12 hours after LEW liver transplanta-
tion induced a transient elevation of SGPT level, while 
intraperitoneal challenge, using spleen cells obtained 
on day 2 after grafting from CsA-treated recipient WF 
rats elicited a rise in SGPT level. These findings sug-
gested that the transient elevation of SGPT was due 
to donor APCs, but not due to donor and host T cells.
Sensitization of third party PVG rats against LEW by 
challenge with LEW-liver carrying WF spleen cells 
 Sensitization against LEW by challenge with LEW-
liver carrying WF spleen cells was investigated using 
skin grafts. Spleen cells were injected intraperitoneally 
into PVG rats 3 days before skin grafting. As shown 
in Table 3. intraperitoneal challenge with LEW-liver 
carrying WF spleen cells obtained 12 hours, but not 
on day 3 after transplantation, sensitized PVG rats 
against LEW.
Table 3. Survival of the skin grafts on PVG rats after an 
intraperitoneal challenge with spleen cells obtained from 
LEW-liver callying WF rats
     Challenge with Ski
n grafts Skin graft survival MGS' 
      spleen cells (days) (days±SD) 
none LEW 8,8,8,8,9, 8.2±0.5 
                             DA 8,8,9, 8.3±0.6
naive WF spleen cells LEW 8,8,8,8,9, 8.2±0.5 
        (3X 108)6 DA 8,8,8, 8.0±0.0 
                            LEW 5,5,5,5,5,6,6, 5.3 ± 0.5'
12h6 (1 X 107) DA 8,8,8, 8.0±0.0 
12h (3X 108) LEW 5,5,5,5,5,6,6, 5.3±0.5d                              DA 8
,8,9, 8.3±0.6 
3 days (1 X 10') LEW 8,8,8,8,9,9,9, 8.4±0.5d 
                             DA 8,8,9, 8.3±0.6
3 days (3X 108) LEW 8,8,8,8,8,9,9, 8.3±0.5d 
                             DA 8,8,9, 8.3±0.5
"MGS: Mean graft survival . 
'Cell number . 
`Time when the host spleen cells were obtained after LEW liver transplantation . 
dP < 0.01.
Flow cytometric analysis 
 We also investigated the presence of donor LEW 
cells in the recipient WF spleen by flow cytometry. As 
shown in Fig. 3. after panning WF cells, LEW cells were 
detected 12 hours after transplantation. The number of 
LEW cells markedly reduced on day 3. The number of 
cells is 1350 ± 220 and 69 ± 26 events, respectively 
(n=3).
In vivo kinetic response of recipient WF rats to donor an-
tigen after LEW liver transplantation 
 In the next step, we examined the kinetics of in 
vivo response of recipient WF rats to donor antigen 
after liver transplantation. Following LEW liver trans-
plantation into WF rats, the rise in SGPT decreased on 
day 7 (SGPT= 69.3 ± 14.2; n=8) and returned to the 
normal level within 14 days (SGPT = 30.1 ± 7.5; n=8) 
as described above. Then, intraperitoneal challenge 
with normal LEW spleen cells (1 x 108) was performed
Fig. 3. Donor LEW cells in the spleen of recipient WF rats 
12 hours (A) and 3 days (B) after liver transplantation, and 
specificity analysis of antiserum (C and D). Recipient spleen 
cells after removal of WF cells with panning procedure (A 
and B), normal LEW spleen cells (C) and normal WF spleen 
cells (D) were incubated with anti-LEW antiserum and FITC-
labeled goat anti-rat IgG (Fc) (gray area). Open area, FITC-
labeled goat anti-rat IgG only. Results of a single experi-
ments, representative of three experiments with similar results.
in recipient WF rats after liver transplantation. As 
shown in Table 4. no response was observed in recipi-
ent WF rats 7 days after transplantation to a chal-
lenge with donor lymphocytes. However, challenge with 
the same cells into recipient WF rats 14, 28, and 56 
days after liver transplantation showed a progressive 
increase in SGPT due to liver damage, and SGPT lev-
els were maximum when LEW spleen cells were chal-
lenged into recipient WF rats over 100 days after 
grafting. These results suggested that recipient WF 
rats showed transient hyporesponsiveness to the donor 
antigen after liver transplantation and the immune re-
Table 4. SGPT in recipient WF rats after an intraperitoneal 
challenge with normal LEW spleen cells
                             SGPT (IU/L)a 
The days after grafting 
0 5 6 14(days)h 
 7 PODc 62±29 55±15 50±8 29±7 
14 POD 36±3 54±14 71±31 35±5 
28 POD 32±9 65±41 85±58 27±3 
56 POD 32±3 102±56 98±25 30±5 
84 POD 31±4 100±43 158±43 32±2 
112 POD 23±6 308±36 330±82 29±4
'Values represent mean ± SD; n=3
. 
'Days after intraperitoneal challenge . 
`POD: postoperative days
.
sponse of the recipiet recovered later.
Discussion
  Following transplantation, donor passenger leuko-
cytes migrate from the graft to secondary lymphoid 
organs of the recipient, a process known to initiate the 
primary immune responses.", 15) In the present study, 
we showed that the alloimmunostimulatory ability of 
the grafted LEW liver disappeared in recipient WF rats 
by day 3 after transplantation. This was confirmed by 
the findings that 5% volume of normal LEW liver ho-
mogenates, but not total volume of grafted LEW liver 
homogenates, could induce transient rejection responses 
in long-term surviving LEW-liver carrying recipient 
WF rats (Table 1) and that grafted LEW liver parked 
for 3 days in primary WF recipients elicited no eleva-
tion of SGPT and TB levels when the graft was re-
transplanted into secondary naive WF rats (n=3, data 
not shown). Furthermore, our results showed that the 
loss of alloimmunostimulatory ability was due to mi-
gration of donor APCs from the liver graft into the re-
cipient. Loss of graft immunogenicity has also been 
shown in kidney transplantation. Batchelor et al.") 
showed that long-term surviving (AS x AUG) F 1 rat 
kidney allografts did not elicit strong alloimmune reac-
tions when re-transplanted into secondary AS recipi-
ents of the same genotype. Those grafts did not con-
tain bone marrow-derived passenger leukocytes of the 
donor.") Dendritic cells from solid organs such as 
heart, kidney and liver showed potent allostimulatory 
ability in vitro."') The time when grafted organs lose 
alloimmunostimulatory ability may vary depending on 
the grafts and strain combinations used. Chui et a133) 
showed that depletion of passenger leukocytes in kid-
ney grafts was achieved by parking the graft for more 
than 14 and 50 days in recipient (AS x AUG) F 1 to 
AS and AUG to AS stain combinations, respectively. 
Welsh et al.34> suggested that the loss of immunogenicity 
of kidney graft was a slow process. 
 A number of immune mechanisms have been postu-
lated for the spontaneous tolerance of the transplanted 
liver.'"') Sun et al. 14,11) suggested that spontaneous liver 
transplant tolerance was a high-dose or activation-as-
sociated immune phenomenon. They argued that donor 
leukocytes appeared to be centrally involved in induc-
tion of liver acceptance. Our study demonstrated that 
immune activation after liver transplantation was due 
to donor APCs that migrated from the graft into the 
recipient lymphoid tissues and that allostimulatory 
ability of recipient spleen was at maximum in those 
obtained at 12 hours after grafting. Thus, a rapid anti-
gen presentation by a large number of donor APCs from 
the graft may result in immunological modulation in 
the recipient in liver transplantation. Interestingly, se-
vere but transient hyporesponsivness against the donor 
antigen occurred early after liver grafting in our 
model. 
  We noted a marked reduction of alloimmunostimulatory 
cells that migrated from the liver graft in the recipient 
spleen by day 3 post-transplantation. In comparison to 
our results, Bishop et al. 27' reported the presence of donor 
cells in recipient lymphoid tissues, which reached a peak 
number on day 1 but not 12 hours after liver trans-
plantation. Larsen et al.` reported that donor-derived 
dendritic leukocytes disappeared in the recipient spleen 
by day 6 after heart transplantation. Furthermore, this 
study showed that donor-type immunostimulatory abitlity 
in the recipient spleen was maintained much longer in 
CsA-treated recipient rats. Cytokine production and re-
cipient CD8 T cells may be associated with the rapid 
depletion of donor cells.27'3J' On the other hand, we ob-
served the restoration of response to the donor antigen 
in the recipients 14-28 days after liver transplantation, 
but most donor APCs from the graft had already been 
eliminated in the recipient by that time. 
 We showed that MHC antigens on the grafted LEW 
liver to be intact since a transient rejection response 
occurred in the long-term surviving grafts by chal-
lenge with donor LEW cells. We previously found that 
the transient rejection response was mediated by CD8 
T cells .31,31' Appropriate stimulation by donor APCs re-
sulted in a transient rejection against the grafted liver. 
Primed cells are able to reject the graft without in-
volving donor APCs,32' but those cells are eliminated 
or inactivated after liver transplantation as we previ-
ously demonstrated.30' 
 Alloimmunostimulatory cells migrating from the liver 
graft were nylon-wool adherent, yet flow cytometric 
analysis showed a number of donor lymphocytes in 
the recipient spleen to be CD3+ cells (data not shown). 
Donor T cells may play a role in liver acceptance due 
to host T cell modulation in nonrejecter rat strain 
combination .21,25' However, donor T cells do not seem 
to be responsible for deletion of primed T cells in the 
recipient. We previously showed that primed CTLs 
could be recovered from WF rats immunized with nor-
mal LEW liver homogenates containing donor T cells, 
but not from LEW liver-transplanted WF recipient rats,30' 
suggesting that the liver graft itself is involved in the 
elimination of primed T cells."' 
 In conclusion, a rapid reduction of donor APCs and 
transient low reactivity of the host immune system 
might explain the induction of tolerance in our model.
Acknowledgment 
 The authors thank T. Terao and S. Urakawa for ex-
cellent technical assistance.
References
1) Singer A, Kruisbeek M, Andrysiak PM: T cell-accessory cell inter-
   actions that initiate allospecific cytotoxic T lymphocyte responses: 
   existence of both la-restricted and la-unrestricted cellular interac-
   tion pathways. J Immunol 132:2199-2209, 1984 
2) Mizuochi T, Golding H, Rosenberg AS, Glimcher LH, Malek TR, 
   Singer A: Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic 
   T lymphocyte responses against allogeneic major histocompatibility 
   antigens but not against trinitrophenyl-modified self. J Exp Med 
   162:427-443, 1985 
3) Singer A, Munitz TI, Golding H, Rosenberg AS, Mizuochi T: Rec-
   ognition requirements for the activation, differentiation and func-
   tion of T-helper cells specific for class II MHC alloantigens. Immunol 
   Rev 98:143-170, 1987 
4) Lechler RI, Batchelor JR: Immunogenicity of retransplanted rat 
   kidney allografts. Effect of inducting chimerism in the first recipi-
   ent and quantitative studies on immunosuppression of the second 
   recipient. J Exp Med 156:1835-1841, 1982 
5) Braun MY, McCormack A, Webb G, Batchelor JR: Mediation of 
   acute but not chronic rejection of MHC-incompatible rat kidney
   grafts by alloreactive CD4 Tcells activated by the direct pathway 
   of sensitization. Transplantation 55:177-182, 1993 
6) Shoskes DA, Wood KJ: Indirect presentation of MHC antigens in 
   transplantation. Immunol Today 15:32-39, 1994 
7) Ingulli E, Mondino A, Khoruts A, Jenkins MK: In vivo detection of 
   dendritic cell antigen presentation to CD4+ T cells. J Exp Med 185: 
   2133-2141, 1997 
8) Steinman RM: The dendritic cell system and its role in immunogenicity. 
   Annu Rev Immunol 9:271-296, 1991 
9) Austyn JM: Antigen uptake and presentation by dendritic leuko-
   cytes. Semin Immunol 4:227-236, 1992 
10) Larsen CP, Ritchie SC, Pearson TC, Linsley PS, Lowry RP: 
   Functional expression of the costimulatory molecule, B7/BB1, on 
   murine dendritic cell populations. J Exp Med 176:1215-1220, 1992
11) Austyn JM, Harkins DF, Larsen CP, Morris PJ, Rao AS, Roake JA: 
   Isolation and characterization of dendritic cells from mouse heart 
   and kidney. J Immunol 152:2401-2410, 1994 
12) Woo J, Lu L, Rao AS, et al: Isolation, phenotype, and allostimulatory 
   activity of mouse liver dendritic cells. Transplantation 58:484-491, 
   1994 
13) Lechler RI, Batchelor JR: Restoration of immunogenicity to passen-
   ger celldepleted kidney allografts by the addition of donor strain 
   dendritic cells. J Exp Med 155:31-41, 1982 
14) Larsen CP, Morris PJ, Austyn JM: Migration of dendritic leuko-
   cytes from cardiac allografts into host spleens. A novel pathway 
   for initiation of rejection. J Exp Med 171:307-314, 1990 
15) Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, 
   Austyn JM: Migration and maturation of Langerhans cells in skin 
   transplants and explants. J Exp Med 172:1483-1493, 1990 
16) Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M: 
   Cell migration, chimerism, and graft acceptance. Lancet 339:1579-
   1582, 1992 
17) Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao 
   AS: The lost chord: microchimerism and allograft survival. Immunol 
   Today 17:577-584, 1996 
18) Calne RY, Sells RA, Pena JR, et al: Induction of immunological 
   tolerance by porcine liver allografts. Nature 233:472-476, 1969 
19) Kamada N, Davies H, Roser B: Reversal of transplantation immu-
   nity by liver grafting. Nature 292:840-842, 1981 
20) Qian S, Fung JJ, Demetris AJ, Ildstad ST, Starzl TE: Orthotopic 
   liver transplantation in the mouse. Transplantation 52:562-564, 1991 
21) Kamada N: The immunology of experimental liver transplantation 
   in the rat. Immunology 55:369-389, 1985 
22) Davies H, Pollard S, Calne R: Soluble HLA antigens in the
   circulation of liver graft recipients. Transplantation 47:524-527, 
   1989 
23) Yoshimura S, Goto S, Kamada N: Immunological tolerance induced 
   by liver grafting in the rat: splenic macrophages and T cells medi-
   ate distinct phases of immunosuppressive activity. Clin Exp Immuno 
   185:121-127, 1991 
24) Sun J, McCaughan GW, Gallagher ND, Ross Sheil AG, Bishop GA: 
   Deletion of spontaneous rat liver allograft acceptance by donor ir-
   radiation. Transplantation 60:233-236, 1995 
25) Sun J, Ross-Sheil AG, Wang C, Wang L, et al: Tolerance to rat 
   liver allografts. IV. Acceptance depends on the quantity of donor 
   tissue and on donor leukocytes. Transplantation 62:1725-1730, 1996 
26) Goto S, Lord R, Kobayashi E, Vari F, Edwards-Smith C, Kamada N: 
   Novel immunosuppressive proteins purified from the serum of 
   liver-retransplanted rats. Transplantation 61:1147-1151, 1996 
27) Bishop GA, Sun J, DeCruz DJ, et al: Tolerance to rat liver allografts. 
   III. Donor cell migration and tolerance-associated cytokine produc-
   tion in peripheral lymphoid tissues. J Immunol 156:4925-4931, 1996 
28) Rugeles MT, Aitouche A, Zeevi A, et al: Evidence for the presence 
   of multilineage chimerism and progenitors of donor dendritic cells 
   in the peripheral blood of bone marrow-augmented organ trans-
   plant recipients. Transplantation 64:735-741, 1997 
29) Qian S, Lu L, Fu F, et al: Apoptosis within spontaneously accepted 
   mouse liver allografts. Evidence for deletion of cytotoxic T cells 
   and implications for tolerance induction. J Immunol 158:4654-4661, 
  1997
30) Yamaguchi J, Kanematsu T, Shiku H, Nakayama E: Long-term sur 
   vival of orthotopic Lewis liver grafts in Wistar Furth rats. Elimination 
   or inactivation of effector CTL and altered antigenicity as possi-
   ble reasons for tolerance. Transplantation 57:412-418, 1994 
31) Valdivia LA, Monden M, Gotoh M, et al: Prolonged survival of 
   hamster-torat liver xenografts using splenectomy and cyclosporine 
   administration. Transplantation 44:759-763, 1987 
32) Batchelor JR, Welsh KI, Maynard A, Burgos H: Failure of long sur 
   viving, passively enhanced kidney allografts to provoke T-dependent 
   alloimmunity. I.Retransplantation of (AS x AUG) F1 kidneys into 
   secondary AS recipients. J Exp Med 150:455-464, 1979 
33) Chui YL, Batchelor JR: Mechanism underlying continued survival 
   of rat kidney allografts after a short period of chemical immu-
   nosuppression. Transplantation 40:150-153, 1985 
34) Welsh KI, Batchelor JR. Maynard A, Burgos H: Failure of long sur-
   viving, passively enhanced kidney allografts to provoke T-
   dependent alloimmunity. II.Retransplantation of (AS x AUG) F1 
   kidneys from AS primary recipient into (AS x WF) FI secondary
   hosts. J Exp Med 150:465-470, 1979 
35) Fast LD: Recipient CD8+ cells are responsible for the rapid elimi-
   nation of allogeneic donor lymphoid cells. J Immunol 157:4805-
   4810, 1996 
36) Yamaguchi J, Ishii T, Kamohara Y, et al: Differences in cellular 
   mechanisms in early and late immunological response after liver 
   transplantation in rats. Transplant Proc 28:1782-1783, 1996
